Colchicine Drugs Market - Introduction
Colchicine drugs are used to treat the symptoms of familial Mediterranean fever and gout. Colchicine was previously available as an unapproved inexpensive generic, by the FDA, but became patented in 2009 by brand-name Colcrys. Familial Mediterranean fever is a hereditary disorder that leads to recurrent episodes of fever. The fever is usually accompanied by pain in the abdomen, chest, or joints. It is typically diagnosed during childhood and occurs in people of Mediterranean origin — including those of North Jewish, Arab, Armenian, Turkish, African, and Greek or Italian ancestry. However, it can occur in any ethnic group. Gout is a form of inflammatory arthritis caused due to excess uric acid. Uric acid is produced in the body after metabolic breakdown of purine nucleotides. A recent study conducted in the U.S. indicated that the incidence of gout has doubled in the past 20 years.
Increase in incidence and prevalence of gout and other related disorders, rise in research and development expenditure, and surge in awareness among people are the factors contributing to the growth of the global colchicine drugs market. Moreover, ongoing clinical studies of colchicine drugs for application in other indications boosts the growth of the global market. For instance, the University College Dublin is conducting phase 3 studies of colchicine for the prevention of vascular inflammation in non-cardio embolic stroke.
Identify the Key Factors that will drive your Company’s Growth. Request a Brochure of this Report here
However, side effects associated with colchicine and disappointing results of clinical studies hamper the growth of the global colchicine drugs market. Moreover, patent loss and launch of generic colchicine leads to sales erosion which further restrains the market. For instance, in July 2018, Par Pharmaceutical (part of Endo International plc) began shipping an authorized generic version of Takeda Pharmaceutical's Colcrys (colchicine) 0.6 mg tablets.
Colchicine drugs Market – Competitive Landscape
Takeda Pharmaceutical Company Limited is a global pharmaceutical company engaged in the manufacture, marketing, and/or distribution of products in various therapeutic classes. The ethical drug segment is engaged in the manufacture and sale of anti-diabetic, cardiovascular, anti-cancer, respiratory, and immunology drugs and vaccines.Takeda has operations in more than 70 countries in regions such as North and South America, Europe, Asia Pacific, and the Middle East.
Endo International plc.
Endo Pharmaceuticals Inc. participates in the research and development, production, sale, and marketing of branded and generic pharmaceutical products primarily in the U.S. The company product portfolio includes comprises of; tablets, extended-release tablets, capsules, injections, clinical research services, and others. The company was founded in 1920 in Malvern, Pennsylvania, U.S. Until 1997 Endo Pharmaceuticals Inc. was known as Endo Laboratories LLC. New product launches is anticipated to assist the growth of the company in global colchicine drugs market during the forecast period. For instance, in July 2018, Par Pharmaceutical (part of Endo International plc.) began shipping an authorized generic version of Takeda Pharmaceutical's Colcrys (colchicine) 0.6 mg tablets.
Other key players operating in the global colchicine drugs market include ROMEG Therapeutics, Genpharma, Prasco Laboratories, Alkem Laboratories, Amneal Pharmaceuticals, Inc., and Zydus Pharmaceuticals, Inc.
Colchicine Drugs Market – Dynamics
Increase in incidence and prevalence of gout and other related disorders
Gout is a form of inflammatory arthritis caused due to excess uric acid. Uric acid is produced in the body after metabolic breakdown of purine nucleotides. The excess uric acid forms crystals in the body which eventually leads to deposition of uric acid crystals in joints, resulting in inflammation and pain. Gout is more prevalent in men than women. It is more prevalent in developed countries than other parts of the world. As of 2013, gout has affected around 5.8 million people, accounting for 1% to 2% of the total western population.
Expanding Operations in Future? To get the perfect launch ask for a Custom Report here
Rise in research and development expenditure, and surge in awareness is anticipated to drive the global Colchicine Drugs Market
Ongoing clinical studies of colchicine drugs for application in other indications boosts the growth of the global market. For instance, the University College Dublin is conducting phase 3 studies of colchicine for the prevention of vascular inflammation in non-cardio embolic stroke.
Side effects associated with colchicine and disappointing results of clinical studies hamper the growth of the global colchicine drugs market
Increasing incidence of side effects due to administration of colchicine are anticipated to hinder growth for global colchicine market during the forecast period. The major side effects of colchicine are muscle pain, weakness, numbness, pale appearance of tongue, lips, severe diarrhea, and others. Physicians recommends emergency medical assistance in case an individual has allergic reaction from colchicine such as hives, swelling, and breathing difficulty.
Colchicine Drugs Market – Segmentation
The colchicine drugs market can be bifurcated on the basis of:
- Distribution Channel
Colchicine Drugs Market Segmentation – By Application
Depending on the application, the colchicine drugs Market can be divided into:
- Familial Mediterranean fever
Colchicine Drugs Market Segmentation – By Distribution Channel
On the basis of the distribution channel, the colchicine drugs can be fragmented into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The report on Colchicine drugs market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The Colchicine drugs market report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The Colchicine drugs market report also maps the qualitative impact of various market factors on Colchicine drugs market segments and geographies.
Regional analysis for Colchicine drugs market includes:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.